Wilson Steven L DDS ,
-
Aurora Bay Area Prices – LISTERIA NIBICTTIGEBES PCR is $120
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10005643, regarding LISTERIA NIBICTTIGEBES PCR, which is classified under revenue code 306 and associated with CPT code 87798, the designated fee stands at $120. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Sheboygan Prices – STENT INTRAVASCULAR EA ADDL VEIN is $19,820.00
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10005196, regarding STENT INTRAVASCULAR EA ADDL VEIN, which is classified under revenue code 360 and associated with CPT code 37239, the designated fee stands at $19,820.00. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Sheboygan Prices – ANGIO FEM-POP + STENT is $24,300.00
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10003642, regarding ANGIO FEM-POP + STENT, which is classified under revenue code 360 and associated with CPT code 37226, the designated fee stands at $24,300.00. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Managing Chronic Neurological Conditions
In conclusion, effective management of chronic neurological conditions necessitates a multifaceted approach that integrates medical treatment, lifestyle adjustments, and psychological support. While advancements in medical science have significantly improved the prognosis and quality of life for many patients, the complexity and individuality of these conditions demand personalized care plans. Ongoing research and interdisciplinary collaboration remain pivotal in addressing the diverse needs of this patient population. Ultimately, empowering patients through education and support is essential for fostering resilience and enhancing long-term outcomes.
